Literature DB >> 3580949

Ferritin content in human cancerous and noncancerous colonic tissue.

C B Vaughn, R Weinstein, B Bond, R Rice, R W Vaughn, A McKendrick, G Ayad, M A Rockwell, R Rocchio.   

Abstract

Tumor tissue samples from 25 patients with adenocarcinoma of the colon, twelve related samples of normal colons as well as five serum specimens from the same patients were analyzed for ferritin. The average ferritin content of the tumor tissue was 788 ng/mcp with a range of 47-1,745 ng/mcp. The average ferritin content of normal colon mucosa was 115 ng/mcp with a range of 32-230 ng/mcp. Two specimens of metastatic colon cancer taken from the retroperitoneal space and liver, respectively, contained 3,867 and 2,827 ng/mcp of ferritin. The ferritin content of the tumor tissue was higher than that of the normal colon in 8 of 9 patients who had specimens obtained from both sites. The amount of ferritin found in tumor tissue was independent of sex, age, and the site of the original tumor. This study shows that the ferritin content of colon neoplasms is elevated and indicates that the tumor tissue may be the direct source of elevated serum levels of ferritin previously observed in cancer patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580949     DOI: 10.3109/07357908709020300

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  11 in total

1.  Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress.

Authors:  Y Tsuji; H Ayaki; S P Whitman; C S Morrow; S V Torti; F M Torti
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 2.  Microbial siderophores and their potential applications: a review.

Authors:  Maumita Saha; Subhasis Sarkar; Biplab Sarkar; Bipin Kumar Sharma; Surajit Bhattacharjee; Prosun Tribedi
Journal:  Environ Sci Pollut Res Int       Date:  2015-03-12       Impact factor: 4.223

3.  The Purified Siderophore from Streptomyces tricolor HM10 Accelerates Recovery from Iron-Deficiency-Induced Anemia in Rats.

Authors:  Hassan Barakat; Kamal A Qureshi; Abdullah S Alsohim; Medhat Rehan
Journal:  Molecules       Date:  2022-06-22       Impact factor: 4.927

4.  FER-1, an enhancer of the ferritin H gene and a target of E1A-mediated transcriptional repression.

Authors:  Y Tsuji; N Akebi; T K Lam; Y Nakabeppu; S V Torti; F M Torti
Journal:  Mol Cell Biol       Date:  1995-09       Impact factor: 4.272

5.  Role of the tumor suppressor PTEN in antioxidant responsive element-mediated transcription and associated histone modifications.

Authors:  Kensuke Sakamoto; Kenta Iwasaki; Hiroyuki Sugiyama; Yoshiaki Tsuji
Journal:  Mol Biol Cell       Date:  2009-01-21       Impact factor: 4.138

6.  Hemochromatosis enhances tumor progression via upregulation of intracellular iron in head and neck cancer.

Authors:  Michelle Lenarduzzi; Angela B Y Hui; Shijun Yue; Emma Ito; Wei Shi; Justin Williams; Jeff Bruce; Noriko Sakemura-Nakatsugawa; Wei Xu; Aaron Schimmer; Fei-Fei Liu
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

Review 7.  Targeting cancer by binding iron: Dissecting cellular signaling pathways.

Authors:  Goldie Y L Lui; Zaklina Kovacevic; Vera Richardson; Angelica M Merlot; Danuta S Kalinowski; Des R Richardson
Journal:  Oncotarget       Date:  2015-08-07

Review 8.  Altered Iron Metabolism and Impact in Cancer Biology, Metastasis, and Immunology.

Authors:  Rikki A M Brown; Kirsty L Richardson; Tasnuva D Kabir; Debbie Trinder; Ruth Ganss; Peter J Leedman
Journal:  Front Oncol       Date:  2020-04-09       Impact factor: 6.244

Review 9.  Intestinal iron homeostasis and colon tumorigenesis.

Authors:  Xiang Xue; Yatrik M Shah
Journal:  Nutrients       Date:  2013-06-28       Impact factor: 5.717

10.  Identification of novel signaling components in N,N'-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma by quantitative phosphoproteomics.

Authors:  Damao Huang; Yuejin Li; Na Liu; Zhenlin Zhang; Zhengke Peng; Chaojun Duan; Xiaowei Tang; Gongjun Tan; Guangrong Yan; Faqing Tang
Journal:  BMC Cancer       Date:  2014-04-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.